Acuta Capital Partners, LLC Aadi Bioscience, Inc. Transaction History
Acuta Capital Partners, LLC
- $98.8 Million
- Q3 2024
A detailed history of Acuta Capital Partners, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 1,849,402 shares of AADI stock, worth $6.27 Million. This represents 3.86% of its overall portfolio holdings.
Number of Shares
1,849,402
Previous 1,849,402
-0.0%
Holding current value
$6.27 Million
Previous $2.7 Million
41.07%
% of portfolio
3.86%
Previous 2.91%
Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
55Shares Held
12.6MCall Options Held
23.8KPut Options Held
0-
Avoro Capital Advisors LLC New York, NY2.85MShares$9.66 Million0.09% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2MShares$6.78 Million2.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.85MShares$6.26 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$2.6 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC526KShares$1.78 Million1.41% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $71.2M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...